1st Quarter - Report

FRESENIUS KABI USA LLC for FRESENIUS KABI USA LLC

Firm
Client
Income
—
Expenses
$25,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Buy America

LobbyistCovered position, as disclosed
TIMOTHY CASEY Congressman John Tierney Senator Tom Carper
SARAH CHRISTINE D'ORSIE Congressman Tom Davis

Contacted: White House Office; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Taxation/Internal Revenue Code TAX

Tax Reform, Section 199, BEAT, Gilty, Buy America

LobbyistCovered position, as disclosed
TIMOTHY CASEY Congressman John Tierney Senator Tom Carper
SARAH CHRISTINE D'ORSIE Congressman Tom Davis

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; White House Office

Pharmacy PHA

Drug pricing legislation, Biosimilars, Patent Reform, Rebate Reform, BLOCKING Act, Electronic Labeling, FDA Foreign Inspection backlog

LobbyistCovered position, as disclosed
TIMOTHY CASEY Congressman John Tierney Senator Tom Carper
SARAH CHRISTINE D'ORSIE Congressman Tom Davis

Contacted: SENATE; Food & Drug Administration (FDA); White House Office; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Medicare/Medicaid MMM

Rebate Reform, Medicare Part D Redesign, Inflationary penalties, Drug pricing legislation, International reference pricing, Medicare direct negotiations

LobbyistCovered position, as disclosed
TIMOTHY CASEY Congressman John Tierney Senator Tom Carper
SARAH CHRISTINE D'ORSIE Congressman Tom Davis

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; White House Office; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.